BSE Live
Mar 13, 16:01Prev. Close
4697.50
Open Price
4651.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 13, 15:49Prev. Close
4695.00
Open Price
4686.00
Bid Price (Qty.)
4623.00 (15)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Pfizer (in Rs. Cr.) | Nov 08 | Nov 07 | Nov 06 | |
| 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 211.22 | 468.69 | 186.01 | |
| Net CashFlow From Operating Activities | 237.76 | 16.45 | 123.19 | |
| Net Cash Used In Investing Activities | -78.87 | 232.53 | 7.46 | |
| Net Cash Used From Financing Activities | -95.20 | -75.90 | -33.82 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 63.69 | 173.09 | 96.83 | |
| Cash And Cash Equivalents Begin of Year | 479.91 | 306.83 | 210.00 | |
| Cash And Cash Equivalents End Of Year | 543.61 | 479.91 | 306.83 |
10.02.2026
Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011
13.03.2026
13.03.2026
11.03.2026
Granules India looks for M&A as it expands beyond the US, deepens focus on complex generics
11.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth